Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.
- Published In:
- The Journal of clinical endocrinology and metabolism (2026)
- Authors:
- Liu, Yi(2), Walzer, Dalia, Schmitz, Sarah, Shukla, Alpana P, Ma, Xiaoyue, Chirko, Dawn, Pipia, Ilissa, Sathi, Swetha, Shukairy, Uthman, Greenberg, Michael, Kashyap, Sangeeta R, Stein, Emily M
- Database ID:
- RPEP-15593
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15593APA
Liu, Yi; Walzer, Dalia; Schmitz, Sarah; Shukla, Alpana P; Ma, Xiaoyue; Chirko, Dawn; Pipia, Ilissa; Sathi, Swetha; Shukairy, Uthman; Greenberg, Michael; Kashyap, Sangeeta R; Stein, Emily M. (2026). Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag052
MLA
Liu, Yi, et al. "Skeletal Effect of Semaglutide and Tirzepatide in Patients with Increased Risk of Fractures.." The Journal of clinical endocrinology and metabolism, 2026. https://doi.org/10.1210/clinem/dgag052
RethinkPeptides
RethinkPeptides Research Database. "Skeletal Effect of Semaglutide and Tirzepatide in Patients w..." RPEP-15593. Retrieved from https://rethinkpeptides.com/research/liu-2026-skeletal-effect-of-semaglutide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.